ABSTRACT: The present paper is intended to be a comprehensive assessment and rationalization, from a statistical mechanics perspective, of existing alchemical theories for binding free energy calculations of ligand−receptor systems. In detail, the statistical mechanics foundation of noncovalent interactions in ligand−receptor systems is revisited, providing a unifying treatment that encompasses the most important variants in the alchemical approaches from the seminal double annihilation method [Jorgensen et al. J. Chem. Phys. 1988; 89, 3742] 
■ INTRODUCTION
The determination of the binding free energy in ligand− receptor systems is the cornerstone of drug discovery. In the last few decades, traditional molecular docking techniques in computer-assisted drug design have been modified, integrated, or superseded using methodologies relying on a more realistic description of the drug−receptor system. It has become increasingly clear that a microscopic description of the solvent is a crucial ingredient to reliably rank the affinity of putative ligands for a given target. 1, 2 In the framework of atomistic molecular dynamics (MD) simulations with explicit solvent, several methods for rigorously determining the absolute binding free energy in noncovalently bonded systems have been devised. Most of these methodologies are based on the socalled alchemical route 3−5 (see refs 6−9 for recent reviews). In this approach, proposed for the first time by Jorgensen et al. 10, 11 and named double annihilation method (DAM), the absolute binding free energy of the ligand−receptor system was obtained by setting up a thermodynamic cycle as indicated in Figure 1 in which the basic quantities to be estimated are the annihilation or decoupling free energies of the ligand in the bound state and in bulk water, indicated hereafter as ΔG b and ΔG u , respectively. These decoupling free energies correspond to the two closing branches of the cycle and are obtained by discretizing the alchemical path connecting the fully interacting and fully decoupled ligand in a number of intermediate nonphysical states and then running MD simulations for each of these states.
Alchemical states are defined by a λ coupling parameter entering the Hamiltonian, varying between 1 and 0, such that at λ = 1 and λ = 0 one has the fully interacting and gas-phase ligand, respectively. ΔG b and ΔG u are usually recovered as a sum of the contributions from each of the λ windows by applying the free energy perturbation method 12 (FEP). Alternatively, and equivalently, one can compute the canonical average of the derivative of the Hamiltonian at the discrete λ points, obtaining the decoupling free energy via numerical thermodynamic integration (TI). 13 Finally, the thermodynamic cycle is closed by computing the difference between the two decoupling free energies along the alchemical path, ΔG b and ΔG u , obtaining the dissociation free energy in solution.
Gilson et al. 14 criticized Jorgensen's theory 10 by pointing out that the resulting dissociation free energy does not depend upon the choice of standard concentration. To define a reference chemical potential for the decoupling ligand when bound to the receptor, Gilson introduced a "restraint" that Figure 1 . Alchemical thermodynamic cycle for computing the absolute dissociation free energy, ΔG 0 , in ligand−receptor systems. The subscripts "sol" and "gas" indicate solvated and gas-phase (decoupled) species, respectively. The ligand−environment interactions must be turned off in the solvated complex and in bulk solvent, obtaining ΔG keeps the ligand in a volume V r around the binding place. This restraint is shown to yield 14−16 an additive standard statedependent correction to the dissociation free energy of k B T ln(V r /V 0 ), interpreted as a chemical potential difference of the ligand at a concentration 1/V r and at the standard concentration 1/V 0 . Gilson et al. named this variant of DAM the double decoupling method (DDM). According to Gilson, the effect of progressively strengthening the restraint, 17 leading to a more negative correction, should be balanced by a larger work integral so that "errors will occur only when the integration region defined by the restraint volume becomes so small that conformations that ought to make important contributions to the work integral are missed." DDM was further developed by Karplus and co-workers 15 who introduced a versatile set of harmonic restraints to be used in MD simulations, restricting both the position and the orientation of the ligand. Hamelberg and McCammon 18 posed the "questions as to how sensitive are the calculated free energies to the strength of the restraining potentials and whether an arbitrary choice of the restraint potential would yield the correct results". The recipe they proposed is to set the force constant in the harmonic restraining potential according to the mean fluctuation of the restrained coordinate in a preliminary unrestrained simulation. Subsequently, Deng and Roux 19 elaborated a DDM variant whereby the standard state correction "in the strong restraint limit" is no longer dependent on the imposed restraint volume V r , hence resolving the alluded inconsistency 17, 20 in the Gilson theory. However, it does apparently require the estimate of an unknown translational, rotational, and conformational binding site volume V site in the complex 21 via an independent unrestrained simulation of the bound state or via an auxiliary FEP for turning on the restraint when the fully coupled ligand is in the binding site. 19, 22, 23 In a series of recent papers, Fujitani and co-workers, 24 The standard state correction issue can be bypassed altogether by computing relative binding free energies 3, 28 due to the transmutation of an unrestrained ligand into another in the same binding site and in the solvent. Relative binding free energy calculations neglect altogether the possibility of a change of binding site volume due to the transmutation or even the possibility that the transmuting ligand may leave the binding site at some alchemical state. This approach is hence limited to the assessment of binding affinities in strictly congeneric series of ligands with the tacit assumption of a constant binding site volume upon transmutation.
In conclusion, the question of the standard state correction or, equivalently, the issue of the binding site volume in drug− receptor dissociation free energy calculations is either ignored, as in calculations of relative free energies, or treated using methodologies relying on the definition of arbitrary sets of constraints whose effects on the resulting free energy have never been convincingly assessed. In any case, the standard state issue and the strictly connected binding site volume definition that is indeed crucial for a reliable MD-based tool in drug discovery, is still far from being settled. In this contribution, we try to address these issues, revisiting the DAM and DDM theories with a spotlight on the relationship between the binding site, restraint, and standard state volumes in noncovalent association, providing a unifying treatment encompassing Jorgensen, Gilson, and Deng and Roux theories.
Corpora Non Agunt Nisi Fixata: 29 Alchemical Theory with Restraints. Molecular recognition in host−guest or drug−receptor noncovalent interactions is based on highly specific molecular complementation, 30 translated as the existence of a single overwhelmingly prevalent binding "pose". The latter can be defined using an appropriate set of coordinates that are functions of the ligand and receptor Cartesian coordinates x. A natural coordinate in ligand− receptor binding is represented by the vector R connecting the center of mass (COM) of the ligand to the COM of the receptor. The vector R defines the precise location of the ligand COM on the receptor surface in the bound state. The orientation of the ligand in the binding site can be specified using the three Euler angles Ω between the receptor frame and the ligand frame or using alternative angular coordinates based on a subset of ligand and receptor atoms. 15, 16 The conformational state in the binding site can be further specified by providing a set of internal coordinates χ of the ligand and the receptor. Overall, a set of translational, orientational, and conformational coordinates, Y (x) ≡ {R(x),Ω(x),χ(x)}, may be used to structurally define the complex. From a theoretical standpoint, this is formally achieved, as we shall see later on, by defining a Heaviside step function Θ(Y) = 1 in a domain marking the relevant ligand−receptor coordinates Y for the associated state. 31 In most applications for the determination of the dissociation free energy using the alchemical method, a set of harmonic restraints are introduced on the Y set of coordinates to keep the ligand in the binding pose while the decoupling process proceeds. The restraint potential in the Y coordinates has the general form
where K is the diagonal matrix of the harmonic force constants. Note that the function e −βV r may be interpreted as a nonnormalized multivariate Gaussian distribution in the space defined by the coordinates Y = {R(x),Ω(x),χ(x)}, i.e.
where the diagonal covariance matrix Σ r is defined as
The parameter Y c in the restraint potential should be chosen so as to match the true mean values of vector Y in the unrestrained complex. In refs 32 and 33 in the context of single molecule pulling experiments, a simple relation was derived between the free energy of the driven system (i.e., with Hamiltonian including the harmonic potential of an external device coupled to a specific molecular distance R) and the free energy of the system with unperturbed Hamiltonian along the driven coordinate (i.e., the potential of mean force along R). The relation proposed by Marsili (eq 7 in ref 32) can be straightforwardly applied to the Y coordinate for any of the restrained λ alchemical states in DDM as 
where we have used the subscript r when referring to quantities of the restrained system and where
r c
B (6) where G r (Y c ,λ) is the free energy of the restrained system ( is a constant that makes the argument of the logarithm adimensional) and G(Y,λ) is the free energy of the unrestrained system at Y with respect to some immaterial reference state at Y * . In eqs 5 and 6, H(x,λ) is the Hamiltonian at the alchemical state λ with x encompassing all solvent, ligand, and receptor coordinates. ρ r (Y|Y c ,λ) ≡ ⟨δ(Y − Y(x))⟩ Y c ,λ , finally, is the canonical probability density evaluated at Y for the system restrained around Y c with free energy at the alchemical state λ given by eq 5.
In the alchemical decoupling of the complex (left branch of the cycle in Figure 1 ), one computes, via FEP or TI, the free energy difference between the states at λ = 1 (interacting ligand) and λ = 0 (noninteracting ligand) subject to the restraint potential V r (x) (eq 1). We can express this difference using general eq 4, thereby obtaining the Y * independent relation 
where for the time being the expanded notation Y = {R,Ω,χ} denotes the set of translational, rotational, and internal ligand− receptor coordinates. In eq 7, the quantity ΔG b r (R c ,Ω c ,χ c ) corresponds to decoupling free energy of the restrained complex, and
is the decoupling free energy of the unrestrained system evaluated at Y = {R,Ω,χ}. Note that, because there is no change in the parameters Y c = {R c ,Ω c ,χ c } in going from the initial (coupled) to the final (decoupled) state, correspondingly, there cannot be a change in the harmonic potential energy at Y = {R,Ω,χ} due to the restraint.
Similarly, it can be shown that, if we restrain the dissociated state of the ligand−receptor system (R = ∞) at the rotational/ conformational state Ω c ,χ c using a harmonic potential, the decoupling free energy of the ligand in this restrained dissociated state (i.e., in the right branch of the cycle of Figure  1 ) is given by where
is the decoupling free energy of the unrestrained ligand in the unbound state evaluated at R ∞ ,Ω,χ. Here, R ∞ represents a ligand−receptor COM distance that is large enough to allow the ligand and the receptor to interact only with the solvent when λ ≠0. Similarly to eq 7, ρ u r (Ω,χ|Ω c ,χ c ,1) and ρ u r (Ω,χ|Ω c ,χ c ,0) are the probability densities of the Ω,χ coordinates for the dissociated (free) ligand, orientationally and conformationally restrained, evaluated at λ = 1 and λ = 0, respectively. ΔG(R ∞ ,Ω,χ) in eq 10 represents the reversible work to bring the ligand in the dissociated state from the bulk into the gas phase when the system is in the ro-vibrational states defined by the vector Ω,χ. All relative ligand−receptor rotational states at R ∞ (i.e., for the separated species) have equal weights 1/8π 2 so that ΔG(R ∞ ,Ω,χ) ≡ ΔG(R ∞ ,χ) depends only on the conformational state χ.
In this regard, we note that the restrained coordinate χ in eqs 7 and 9 may in principle also include conformational coordinates of the receptor. In such a case, because only the ligand is annihilated in the right branch of the cycle in Figure 1 (the dissociated state), the alchemical contribution to the decoupling free energy comes only from the ligand with no contribution from the χ-restrained unbound protein. Nonetheless, as we shall see later on, restraining the conformational state of the protein indeed has an impact on the alchemically computed dissociation free energy.
By subtracting eq 10 from eq 8, we obtain
where we have exploited the fact that the probability densities of the decoupled ligand and receptor (λ = 0) are uniform over R. χ Ω R ( , , ) represents the reversible work for bringing the separated (R ∞ ) ligand and receptor in the Ω,χ arrangement into the corresponding bound conformation at R. As the function χ Ω R ( , , ) for R ∞ does not depend on Ω but may depend on χ, it is convenient to express the reversible work χ Ω R ( , , ) in terms of potentials of mean force, evaluated with respect to an arbitrary reference conformational state χ * for the separated species, i.e.
with
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In eq 13, w(R ∞ ,χ) represents the reversible work to bring the separated system from the χ * conformational arrangement to the new conformational state χ, and w(R,Ω,χ) is the reversible work to bring the separated system at χ * and with relative orientation expressed by Ω to the bound state defined by the coordinates R,Ω,χ.
To close the alchemical thermodynamic cycle, we subtract eq 9 from eq 7 and use eq 11 by setting 
where to remove the excess baggage from the formalism we have redefined the probability density for the restrained system as 
with λ = 0 or λ = 1. Eq 14 expresses the fact that the dissociation free energy of the restrained system, computed in alchemical simulations via FEP or TI; namely, the quantity 
is equal to minus the reversible work for forming the complex plus a correction related to the logarithm of the ratio of the canonical probability densities for the restrained decoupled and coupled bound and separated states. It should be stressed that, for eq 14 to be valid, the canonical probability densities at the end states, ρ b r (R,Ω,χ|0,1) and ρ u r (Ω,χ|0,1), must be both evaluated with the restraint in place. The strength of the harmonic potentials, restraining the bound state (left branch) around R c ,Ω c ,χ c or restraining the rotational/conformational free ligand (right branch) around Ω c ,χ c can be set independently.
How then does the FEP or TI computed DDM dissociation free energy ΔG d r (R c ,Ω c ,χ c ) of the restrained system relate to the standard dissociation free energy ΔG 
where J(R,Ω) is the Jacobian of the transformation from Cartesian to the relative translational orientational coordinates R,Ω and where Θ(R,Ω,χ) is a Heaviside step function (sometimes referred as the indicator function 14, 21, 34 ) defining the region of existence of the complex between the receptor and ligand in the R,Ω,χ space. In the second line of eq 17, in the denominator we have exploited the fact that, as V → ∞ (infinite dilution limit), w(R,Ω,χ) can be taken to be equal to w(R ∞ ,χ) everywhere so that we can perform the integral on the R,Ω coordinates obtaining the factor 8π 2 V. In the last equality, we have used the definition eq 12 for the reversible work χ Ω R ( , , ) in terms of the potential of mean force (PMF) with respect to an arbitrary reference conformational state.
The integral in brackets in the numerator of eq 17 (that has the dimension of a volume and square radiants) can be expressed in terms of an effective volume V b (χ) times the exponential of the potential of mean force at the point R χ ,Ω χ ,χ, corresponding to the minimum value of the ligand receptor reversible work function given a χ conformation. This effective binding site volume V b (χ) depends in the general on the conformational state χ of the ligand and the receptor. The same holds true for the minimum value in the R,Ω space of the reversible work function at fixed χ. Conformational states (e.g., extended vs compact configurations of a flexible ramified ligand) can be characterized by different inertia moments with an impact on the size and shape of the volume V b (χ)). In particular, V b (χ) may be equal to zero (or equivalently the indicator function Θ(R,Ω,χ) is zero everywhere) for conformational states that are incompatible with the complex. In summary, given the conformation χ, the choices of the point R χ ,Ω χ and of the corresponding effective volume V b (χ) are intertwined so as to satisfy eq 17.
To define more precisely this χ-dependent effective rototranslational volume V b (χ), we rewrite the integral in brackets in eq 17 with respect to the six external coordinates X = R,Ω using a multivariate Gaussian distribution of appropriate covariance Σ b (χ), i.e. 
so that 
If we choose a diagonal covariance matrix satisfying eq 19, and given that the Jacobian has the factorized form 
where Σ b T (χ) and Σ b Ω (χ) are 3 × 3 diagonal covariance matrices corresponding to the translational and orientational block.
Using eqs 18 and 19, eq 17 may be rearranged as
where
expresses the canonical probability density for the χ conformational state of the separated species. Suppose now, as schematically depicted in Figure 2 , that function Θ(R,Ω,χ) is nonzero only for N c disconnected domains Δχ i of the χ coordinates, i.e. that binding can occur in N c conformationally distinct poses, each with a rototranslational volume V b (χ i ) around the local minimum of the PMF at the point R i ,Ω i ,χ i . Then, by appropriately selecting the volumes V b (χ i ) and the points R i ,Ω i ,χ i in the N c conformational basins, we can rewrite the integral eq 22 as
where we have defined the conformational weights of the N c poses as term. The free energy difference that refers to the separated species at χ c and χ u (where the latter is the most favorable conformational state of the separated species) is called the binding reorganization energy, measuring energetic strain and entropic factors that oppose binding. 35, 36 Taking into account that
, eq 26 can be equivalently written in terms of dissociation free energy as 
where we have defined the overall binding site volume as
Eq 28 is the central result of this paper and provides a general relation embracing (as we shall see further on) all current alchemical theories from the DAM approach, 10,11 with (apparently) no restraints, to the Deng and Roux method 19 with strong restraints. Eq 28 says that the standard or absolute dissociation free energy, ΔG d 0 , is given by the simulation dissociation free energy on the restrained systems, ΔG d r (Y c ), plus a composite standard state correction due to the allowance volume and probability density ratios that strictly depends on the imposed translational and (possibly) orientational/conformational harmonic restraints. When restraints on R, Ω, and χ are imposed, the "translational volume" V T (χ c ) and the "rotational volume", V Ω (χ c ), defined in eq 21 are both a function of the restrained conformational coordinates. When only translational and orientational restraints are imposed, and the canonical sampling of the accessible conformational space has been attained for all λ states in either branch of the cycle, then the volume V b = V T V Ω has, correspondingly, translational and orientational components that are independent of the conformational state in the bound or free state. By the same token, the probability density ratios in eq 28 become independent of the (unrestrained) conformational coordinate χ. If the harmonic restraints are imposed only on translations, i.e., Y = R, provided that the orientational sampling of the translationally restrained bound state is canonical for all λ states in either branch of the cycle, then only the volume V T and the probability density ratio for bound state alone are needed in the correction.
Finally, we remark that although the restraining orientational and conformational parameters Ω c ,χ c (if present) must be identical when decoupling the bound and free ligands, the force constant K can be selected independently. By imposing an infinitely stiff force constant when decoupling the orientationally and conformationally restrained ligand in bulk, we have that ρ u r (Ω c ,χ c |0) = ρ u r (Ω c ,χ c |1). Eq 28 can hence be compactly rewritten as Deng and Roux's Theory: Stiff Restraint Regime. When K → ∞ also in the bound state, i.e., in the so-called stiff-spring regime, 32,37 the last logarithmic terms on the rhs of eq 28 are zero because the probability densities for the restrained bound and free ligands in the λ = 1 and λ = 0 states become identical. According to eq 14, the alchemically determined dissociation free energy (eq 16), ΔG d r (R c ,Ω c ,χ c ), can be thus taken to be equal to minus the reversible work χ Ω R ( , , ) evaluated at the restraint value {R c ,Ω c ,χ c }, i.e. 
The volumes V T (χ c ) and V Ω (χ c ) and the factor W(χ c ) are related to the oscillations of the R,Ω,χ coordinates when the ligand and the receptor are in the conformational basin with minimum χ c . As suggested in ref 18, these volumes should be determined in a preliminary unrestrained simulation of the complex. 38 When imposing strong restraints on R,Ω,χ, it is tacitly assumed that the ligand can perform only small librations around the minimum R c ,Ω c ,χ c defining the binding site and that the binding state is characterized by a single conformational pose around χ c (i.e., eq 26 holds). One can see the three logarithmic terms in eq 32 as a translational, rotational, and conformational entropy loss of the bound state, producing a penalty in the binding affinity. Hence, the more tightly the ligand is bound in the pocket, the smaller the "volumes" V T (χ), V Ω (χ), and W(χ) will be and the larger is the entropy loss due to association. We may hence say that eq 32 constitutes the statistical mechanics foundation of a sophisticated docking approach: the function
is evaluated by the alchemical decoupling of the complex, tightly restrained at R c ,Ω c ,χ c , and of the free ligand, tightly restrained at Ω c ,χ c . In molecular docking, the solvent averaged energetic contribution,
is evaluated on the end-points using molecular mechanics Poisson−Boltzmann surface area (MM/PBSA)) 39, 40 or the molecular mechanics-generalized Born surface area (MM/GBSA) 40−42 models, whereas the elusive volume entropic contributions are evaluated using either MD methodologies 43, 44 or simplified analytic estimates. 45 It is important to stress that the size and the units of the can somehow be estimated in independent unrestrained simulations of the complex 38 (needed for measuring V T (χ) and V Ω (χ c )) and of the free ligand (needed for measuring W(χ c )), eq 32 allows for computing the absolute dissociation free energy from the difference of the decoupling free energies of the free ligand and of the complex obtained by FEP or TI, where the latter is tightly kept at the R c ,Ω c ,χ c ligand−receptor position by a set of strong restraints of the form of eq 1. Although R and Ω are relative ligand receptor external coordinates involving the atoms of both species, the χ coordinates in general involve only atoms of the ligand, typically expressed using dihedral angles. 15, 19, 23 This is so because when the ligand is annihilated in the left branch of the alchemical cycle, the free protein must not experience any restraint. If χ is chosen so as to also include (or affect) conformational coordinates of the protein, then the restraint on χ affects the motion (and the sampling) of the protein when the ligand is annihilated. In such a case, an unrestrained simulation of the free protein is in principle necessary to determine the overall conformational weight W(χ c ) for the separated species entering eq 32.
Eq 32 was previously derived using a different route by Boresch et al. 15 and by Deng and Roux; 19 it does not explicitly depend on the imposed restraint potential, 38 hence resolving the inconsistency when one lets the volume V r (i.e., in the stiff restraint limit) go to zero in the Gilson's standard state correction term k B T ln(V r /V 0 ). In the strong restraint approach, however, the estimate of the dissociation free energy crucially depends on the estimate of the unknown binding site volume . First of all, the number and nature of ligand and receptor conformational coordinates participating in binding is not known from the start. Second, regardless of the choice, because of the inherent conformational flexibility of many ligands and of virtually all receptors, these coordinates will be coupled to other ligand and receptor coordinates such that
Article restraining them may make it harder or even prevent sampling of configurational states that are relevant for binding. In some sense, DDM theory with strong restraints appears essentially to be based on the traditional picture of a "lock and key" model 46 with a systematic underestimation of receptor and ligand conformational reshaping upon binding ("induced fit" model 47 ). Gilson, Bush, Given, and McCammon theory: Intermediate Restraint Regime. We now assume that we impose only translational and orientational restraints and that these restraints, when applied to the bound state (left branch of the cycle), are weak enough to allow the ligand−receptor system to canonically sample all χ conformational states that are important for binding. We then set an infinitely stiff orientational restraint in the right branch of the cycle so that eq 30 can be used, i.e. 
where the binding site volume V b = V T V Ω accounts for translational and rotational contribution. The probability density of the restrained fully decoupled ligand in the binding site,
where we have used eqs 1 and 3 and V r ≡ V r (Σ r ) defines the temperature-dependent allowance restraint volume such that V r contains the unknown roto-translational binding site volume 
where we have set Σ b so that
In the assumption that the last term is small and can be neglected (i.e., V r ≫ V b ), and factoring the restraint volume V r in translational and orientational parts V I ,ξ I , then eq 36 is identical to the equation proposed by Gilson. 49 Note also that, when V r ≪ V b , the probability density at Y c of the fully coupled bound state, ρ(Y c |1) (eq 35), becomes identical to that of the fully decoupled bound state, ρ(Y c |0), thus recovering the stiff regime result involving V b only (i.e., obtaining eq 32 lacking the conformational term).
As On the other hand, DDM with weak restraint potentials should be handled with due care by practitioners. In the case of highly symmetric ligands like benzene bound to T-lysozime, 19 for example, orientational restraints may prevent the sampling of the bound conformations that are defined by a mere exchange of the atom labels due to rotational operations of the symmetry group of the ligand (say σ), underestimating the orientational volume in the bound state and hence the dissociation free energy. If the orientational restraint prevents the sampling of any of the equivalent σ = 12 states of benzene, then the free energy should be corrected by an additive volume term k B T ln 12 apparently due to "symmetry". 50, 51 If instead the restraints are engineered so that they allow the sampling of the bound states that are generated by rotations around the 6-fold axis of the benzene molecule but not of those that can be generated by rotation around the 2-fold symmetry axis, then the correction factor reduces to k B T ln 2. Symmetry numbers therefore enter into Gilson's theory as volume correction factors. In other words, the imposed restraint may prevent the sampling of an orientationally equivalent configuration, even if only a translational restraint is imposed. In the case of the benzene ligand, if the restraint on R is too tight (or the simulation too short), then the ligand may not be allowed to partially leave the binding pocket so that it can rotate around the symmetry axis to sample different configuration of the atom labels, i.e., to visit the underlying orientational volume V Ω .
This kind of "symmetry" correction should also apply to the Deng and Roux DDM variant with strong restraints if V b (Ω χ ) was estimated from the librations of the unrestrained ligand in just one of the equivalent orientational poses, thus underestimating the actual orientational volume.

Article
Jorgensen's Theory: Unrestrained (DAM) Regime. What happens when we instead let the force constant K → 0 in eqs 28 and 30? The ligand in unrestrained simulations is mistakenly considered as "free to wander", whereas actually its concentration (or restraint volume V box ) is externally imposed by the periodic boundary conditions (PBC) used in the simulation. As noted in refs 15 and 23, the resulting V boxdependent free energy should hence be related to the standard dissociation free energy as
This result can be obtained by applying the K → 0 limit of general eq 30 and assuming that only a restraint on R is imposed in the left branch of the cycle, i.e. (38) where V T = e βw(R c ) ∫ V b e −βw(R) J(R) dR is the allowance oscillation volume of the COM vector distance R in the complex irrespective of the ligand−receptor orientational and conformational coordinates. In the limit |Σ| → 0, the restraint the probability density of the decoupled ligand in bound state is uniform and is given by
The probability density of the coupled system at R = R c , ρ b r (R c | 1) is simply given by 52 Nonetheless, as discussed in the Introduction, the unrestrained DAM approach is still used in ligand−receptor systems, 25,27 providing in general good estimates of the dissociation free energies. In this regard, it has been recently proposed, 9, 53, 54 that these unrestrained DAM simulations actually express a nonequilibrium measure of the dissociation free energy that is close to the real equilibrium value because of well-grounded theoretical reasons stemming from nonequilibrium thermodynamics.
■ CONCLUSIONS
In this paper, the statistical mechanics of noncovalent bonding in drug−receptor systems has been revisited. It has been shown that all existing alchemical theories in binding free energy calculations can be rationalized in terms of a unifying treatment encompassing the original unrestrained DAM, 10,11 the Gilson's restrained DDM variant, 14 and the sophisticated docking approach proposed by Deng and Roux. 19 According to general eq 30 relating the alchemically determined free energy difference to the standard dissociation free energy, the cited alchemical theories differ in the definition (explicit or implicit) of the binding site volume through the enforcement of a set of appropriately selected restraint potentials.
The strong restraint approach 19 evaluates the potential of mean force at the bottom of the well Y c , relying on a precise knowledge of the binding pose volume V b entering in the standard state correction. As such, the Deng and Roux alchemical theory can be considered as a sophisticated docking approach where only a single pose is assessed in the context of the traditional picture of the lock and key model (see Figure 3) . The strong restraint approach, by limiting the sampling space, is in general assumed to converge more easily. 19 On the other hand, we have seen that this methodology may underestimate the effective binding site volume by preventing the sampling of conformational states that are important for binding. In the intermediate regime, conformational (and possibly orientational as well) restraints are lifted, and restraints on external coordinates are weakened so that the ligand can now move in the binding pocket within a volume V r without drifting off in the bulk. In this case, provided that V r contains the underlying binding site volume V b , eq 30 becomes equivalent to the Gilson formula eq 36 with V b being replaced by the parameter V r in the standard state correction. In the intermediate regime, the dissociation free energy estimate is in principle independent of the chosen parameter V r due to the compensation effect on the alchemical free energy difference ΔG b − ΔG u when V r is made larger, given that the simulations have converged at all λ states.
When the force constant of the restraint potential is made infinitely small, only the translational restraints imposed by the PBC survives. The ligand must hence sample all states that are made accessible at the concentration 1/V box in all λ thermodynamic states, possibly including a fraction of unbound states at λ = 1. Alchemical decoupling becomes cumbersome, and the DDM theory becomes equivalent to the DAM theory provided that the standard state correction k B T ln(V box /V 0 ) is used and that e . DAM, although it may be considered as a special case of the Gilson's DDM theory with V r = V box , is not viable in practice due to the difficulties in the sampling of ligand−receptor configurations in the entire simulation box for all λ thermodynamic states.
If the restraint is weak and involves only the translational coordinate R, the ligand−receptor PMF and the underlying binding site volume V b ≡ V T are modulated by the rovibrational coordinates of both the ligand and the receptor, as schematically depicted in Figure 3 . As first remarked in ref 14 , the integral defining the equilibrium constant in terms of the exponential of the PMF can be extended beyond the domain where the indicator function is equal to one with no appreciable change in K d . It then follows that K d depends only weakly on the specific definition of V b , provided that such a domain includes all of the important R,Ω regions of the binding site volume. 14, 34, 55 The use of a weak restraint in the context of the alchemical theory implies weaker assumptions on the pose topology and nature, hence progressively shifting the approach toward a more realistic induced fit/conformational proofreading model in drug−receptor interactions. As remarked in the seminal papers of refs 14 and 19, the price to pay is that the choice of a larger V r expands the sampling of the accessible ligand− receptor configurational space in the left branch of the alchemical cycle to regions of low PMF yielding a negligible contribution to the dissociation constant. These regions, however, may be the only access to the sampling alternate low free energy poses contributing to binding. This sampling expansion in DDM with weak restraints may be more relevant for the low value of the alchemical coupling parameter λ (when the ligand starts to be loosely bound to the binding site), making the overall convergence of the FEP or TI simulation harder.
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